Decarboxylation: THCA, THC, and the Limits of Time Estimates
Short answer: Decarboxylation is the removal of a carboxyl group with release of carbon dioxide. In cannabis this concerns, for example, the conversion of THCA to THC or CBDA to CBD. The reaction is not the same as vaporization. A universal time–temperature value for complete conversion of every sample cannot be derived from it.
What changes during decarboxylation?
The chemical structure of a molecule changes. This distinguishes the reaction from a simple transition between liquid and gaseous phases. For this reason, ‘activating’, ‘vaporizing’ and ‘extracting’ should not be used as synonyms without explanation.
THCA and THC are distinct compounds. The same applies to CBDA and CBD. Analytical data must likewise distinguish between these forms. A calculated total value is only meaningful when it is explained which substances were measured and how they were converted.
The widespread shorthand ‘acid form to active form’ also oversimplifies the biological side. A chemical conversion does not entail a universal medical effect or therapeutic benefit for every product.
Why do time and temperature belong together?
A reaction has a temporal progression. Reaching a target value on a display is not identical to a completed reaction conversion. The sample must first actually reach that temperature; localised differences may occur during this process.
The matrix also plays a role. An extract in a laboratory vessel is not the same sample as loosely or densely packed flower in a chamber. Likewise, a vacuum oven, a domestic appliance and a flow-through vaporizer represent different experimental conditions.
A time figure may therefore only be carried over together with the material and setup that were studied. Where these details are absent, a seemingly precise protocol is easily created that is not supported by the original study.
What distinguishes reaction conversion, yield and delivery?
The table separates three measurement questions that are frequently conflated. It also shows why the disappearance of a precursor does not automatically prove that the entire corresponding quantity of the target compound reaches the mouthpiece.
| Measurement question | What is being examined | What else remains uncertain |
|---|---|---|
| Reaction conversion | Change in a starting compound | Which products are formed exactly |
| Product yield | Recovered mass of a target compound | Losses or further reaction products |
| Aerosol delivery | Quantity of substance captured at the collection point | Residual material, device deposits, and systemic uptake |
A device can facilitate a chemical conversion whilst simultaneously delivering only a portion of the target compound to the respective collection point. For a complete assessment, these processes must be measured separately.
What does vaporizer research show on this?
Lanz et al. examined both acidic and neutral cannabinoids as well as various fractions of the delivery system. The methods box sets out the specific conditions. The study is a device experiment and not a universal evaluation of every heating method.
The study therefore does not justify any claim that conversion is complete within fractions of a second in every vaporizer. Nor can a high conversion measured with one model be straightforwardly transferred to a different material or a different procedure.
A proper study description states the measurement method, starting material, number of replicates, and time point. Percentage values without this context have been removed from the present version.
Why are boiling points not reaction temperatures?
A boiling point is a physical value for a substance at a defined pressure. It does not directly describe the rate of a chemical reaction. A table of boiling points for THC or terpenes therefore does not constitute a complete decarboxylation protocol.
Equally, a setting at which a device produces an aerosol does not prove complete conversion of the entire sample. Compounds already released and those still present can simultaneously exist in different states.
The contextualisation of boiling points explains this limitation in greater detail. This also means that temperature does not allow a fixed selection of individual effects.
What happens to terpenes and other constituents?
A cannabis sample contains more than just a single precursor and its conversion product. During heating, the relative composition and the distribution between sample, surroundings, and device can change. This must be measured when making a claim such as “complete profile preserved”.
The mere presence of terpenes does not, however, demonstrate a stronger therapeutic effect following processing. Appropriate clinical comparisons would be required for that. The terpene evidence overview explains which claims have actually been investigated.
The formation of further products is likewise not described by a single blanket threshold value applicable to all procedures. Temperature, duration, and material must correspond to the respective emissions study. A dabbing experiment does not automatically serve as evidence for a domestic oven.
How can a decarboxylation study be evaluated?
Look for the material studied, the temperature measurement, and the sample preparation. Was the target temperature or the actual sample temperature reported? Was the work carried out in air, under inert gas, or at reduced pressure? How were the compounds separated analytically?
It also matters whether only the disappearance of the acid or simultaneously the appearance of the neutral compound was measured. A difference cannot automatically be counted as the desired product. Measurement uncertainty and unrecovered fractions must be included in the interpretation.
A sound translation of these data into a practical guide stays close to the data. It does not turn a single laboratory procedure into a universal instruction for unknown kitchen or device conditions.
Has already vaped material been fully converted?
Not necessarily. The term AVB describes the history of use, not a standardised degree of reaction conversion. Colour and the temperature setting used previously do not constitute a complete analysis.
Even if conversion has taken place, the remaining quantity of compound may be unknown. The AVB classification therefore explains separately what can be inferred from a spent sample and what remains open.
Does cannabis need to be additionally heated before use in a dry-herb vaporizer?
For the electrical devices tested by Lanz, extensive decarboxylation occurred under the respective vaporization protocol. This shows that conversion during device operation is possible. An additional pre-treatment cannot be derived from this as a general prerequisite. At the same time, the finding is not evidence applicable to every device or every mode of use. Lanz et al. (2016)
For medical use, the specifications of the preparation and the intended delivery system are authoritative. A general glossary text can neither replace product-specific instructions nor provide a therapeutic assessment of a modified preparation.
Frequently Asked Questions
Is decarboxylation the same as vaporization?
No. One is a chemical reaction; the other is a phase transition or mass transfer.
Is there a universal time for complete conversion?
No. The material, the actual temperature profile, and the apparatus all influence the outcome.
Does less THCA automatically prove the same amount of additional THC?
Not without an appropriate mass balance. Products, further transformations, and detection limits must all be taken into account.
Is everything fully decarboxylated after vaporizing?
This cannot be inferred from a completed session alone, or from the colour of the spent material.
Source status and corrections
Last updated: 10 September 2026. The scientific reference is the device experiment by Lanz et al. described in the methods box. Removed were unsubstantiated universal time schedules, blanket claims about therapeutic effects, and the equation of complete chemical conversion with complete release of active compound.
Lanz C et al. (2016)
- Study
- In-vitro device and aerosol validation
- Sample
- No human participants; 5 commercial dry-herb vaporizers, THC-dominant and CBD-dominant plant material.
- Comparison and measurement
- GC/MS for cannabinoid recovery in collected aerosol, HPLC for acidic cannabinoids and decarboxylation; Volcano Medic, Plenty, Arizer Solo, DaVinci, and a gas-powered device.
- Randomisation and blinding
- Not applicable.
- Result
- Electrically temperature-controlled devices decarboxylated THC/CBD very efficiently and delivered cannabinoids reproducibly; combustion was observed with the gas-powered device.
- Strengths
- Validated analytical methods; multiple devices; direct measurement of material transfer.
- Limitations and potential bias
- No human participants, no clinical endpoints, no comprehensive toxicological aerosol analysis; device generations are older.
Lanz C, Mattsson J, Soydaner U, Brenneisen R. 2016. Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis. PloS one. DOI: 10.1371/journal.pone.0147286 · PMID 26784441 · PMC4718604
Lanz C, Mattsson J, Soydaner U, Brenneisen R. 2016. Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis. PloS one. DOI: 10.1371/journal.pone.0147286 · PMID 26784441 · PMC4718604